Congressional Conversations: Lawmakers Focus on Safeguards for AI Development
Congress continued its AI policy blitz following the release of the Trump Administration’s AI Action Plan in late July. Although much of the conversation surrounding AI policy has centered on the need to regulate chatbots, especially those used for mental health applications, lawmakers from both parties have expressed interest in developing policy for AI applications in medicine.
Earlier this month, the Senate Health, Education, Labor, and Pensions (HELP) Committee held a hearing on AI's Potential to Support Patients, Workers, Children, and Families. During the hearing, lawmakers highlighted the need to use high-quality, representative data to train AI systems. Senators also emphasized the need for physicians to play a role in supervising AI applications in clinical settings and explored the issue of liability when AI is used in patient care.
Senator Josh Hawley (R-MO) and Senator Richard Durbin (D-IL) affirmed their interest in AI liability policy by introducing the Aligning Incentives for Leadership, Excellence, and Advancement in Development Act (S. 2937), which would allow individuals to sue the developer of AI tools for any harm that their products may cause. Although this bill does not specifically call out health care technology, it demonstrates the ongoing congressional interest in developing policies to protect individuals from harm related to the use of AI.
RSNA Government Relations will continue to monitor policy developments regarding AI applications in medicine.
Immigration Insights: Recent Policy Changes and Impacts for the Health Care Enterprise
Over the past several months, the Trump Administration has announced several policy changes to the immigration process for skilled workers, including International Medical Graduates (IMGs) coming to the United States for additional medical training. Thousands of IMGs come to the United States each year on J-1 and H-1B visas to complete their medical residency. IMGs are essential to the U.S. medical workforce, filling approximately 30% of all residency positions across all specialties and accounting for approximately 10% of radiology residency spots, according to data from the National Resident Matching Program (NRMP).
In August, the Trump Administration issued a Notice of Public Rulemaking (NPRM) to change admission for skilled workers on an F, J, or I visa. Under the current system, IMGs can stay in the U.S. under the duration of status (D/S) classification, which allows trainees to remain in the country for the duration of their training program without needing to complete additional documentation. The NPRM proposes to eliminate the D/S classification and require a fixed maximum 4-year stay for individuals on an F, J, or I visa. IMGs who rely on these visas for their training would need to apply for an extension of stay, causing a potentially harmful disruption to their education.
Adding to concerns among medical education and research organizations, President Trump issued a proclamation that significantly increased the fee employers must pay to obtain an H-1B visa for employees. This proclamation went into effect immediately, generating concern over the impact this could have on existing health care workforce shortages. The proclamation does provide fee exemptions to classes of workers identified as serving in the national interest, although it remains unclear if IMGs qualify for this status.
RSNA Government Relations will continue tracking updates related to U.S. immigration policy and its impacts on the medical workforce as we expand our efforts in this domain.